|Bid||26.80 x 800|
|Ask||42.83 x 900|
|Day's Range||25.59 - 27.04|
|52 Week Range||21.06 - 79.75|
|Beta (5Y Monthly)||1.37|
|PE Ratio (TTM)||19.95|
|Earnings Date||May 05, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.88|
Subscribe to Yahoo Finance Plus to view Fair Value for PRTA
With its stock down 30% over the past three months, it is easy to disregard Prothena (NASDAQ:PRTA). However, a closer...
Epizyme (EPZM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DUBLIN, Ireland, June 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday June 8, 2022 at 8:30 AM ET. A live webcast of the fireside chat can be accessed through the investor relations section of